CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2021-08-24

Reporting Person: COELHO PHILIP H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-24	Common stock, par value $0.001 per share	M	16667	$3.12	Acquired	233427	Direct
2021-08-24	Common stock, par value $0.001 per share	S	9494	$5.575	Disposed	223933	Direct
2021-08-25	Common stock, par value $0.001 per share	M	16667	$3.12	Acquired	240600	Direct
2021-08-25	Common stock, par value $0.001 per share	S	9498	$5.56	Disposed	231102	Direct
2021-08-26	Common stock, par value $0.001 per share	M	16666	$3.12	Acquired	247768	Direct
2021-08-26	Common stock, par value $0.001 per share	S	9044	$5.45	Disposed	238724	Direct
2021-08-26	Common stock, par value $0.001 per share	S	504	$5.46	Disposed	238220	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-24	Options to purchase common stock	$3.12	M	16667	Disposed	2021-08-28	Common Stock (16667)	Direct
2021-08-25	Options to purchase common stock	$3.12	M	16667	Disposed	2021-08-28	Common Stock (16667)	Direct
2021-08-26	Options to purchase common stock	$3.12	M	16666	Disposed	2021-08-28	Common Stock (16666)	Direct

Footnotes

F1: Shares were sold to cover exercise price of options.

F2: Options vested in two annual tranches beginning on August 28, 2014.